Nonalcoholic fatty liver disease induced by 13-week oral administration of 1,3-dichloro-2-propanol in C57BL/6J mice
- 1 May 2015
- journal article
- Published by Elsevier in Environmental Toxicology and Pharmacology
- Vol. 39 (3) , 1115-1121
Abstract
No abstract availableKeywords
Funding Information
- Foundation of China (31130053, 2013BAD16B09)
This publication has 20 references indexed in Scilit:
- Nonalcoholic Fatty Liver Disease/Steatohepatitis: Epidemiology, Pathogenesis, Clinical Presentation and TreatmentDigestive Diseases, 2012
- Role of the AMPK/SREBP-1 pathway in the development of orotic acid-induced fatty liverJournal of Lipid Research, 2011
- Application of the margin of exposure (MoE) approach to substances in food that are genotoxic and carcinogenicFood and Chemical Toxicology, 2010
- Developmental toxic potential of 1,3-dichloro-2-propanol in Sprague–Dawley ratsRegulatory Toxicology and Pharmacology, 2009
- Structural basis for AMP binding to mammalian AMP-activated protein kinaseNature, 2007
- Deriving a Data-Based Interspecies Assessment Factor Using the NOAEL and the Benchmark Dose ApproachCritical Reviews in Toxicology, 2007
- Molecular identification of microsomal acyl-CoA:glycerol-3-phosphate acyltransferase, a key enzyme in de novo triacylglycerol synthesisProceedings of the National Academy of Sciences, 2006
- Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant miceProceedings of the National Academy of Sciences, 2006
- LKB1-Dependent Signaling PathwaysAnnual Review of Biochemistry, 2006
- The clinical features, diagnosis and natural history of nonalcoholic fatty liver diseaseClinics in Liver Disease, 2004